# Development of peptide nucleic acid antibiotics-supplement 1

> **NIH NIH R42** · NUBAD, LLC · 2024 · $133,089

## Abstract

This supplement request describes the research and training plan for an
underrepresented candidate with background in organic chemistry and an
aspiration to become an independent investigator in antimicrobial resistance.
The candidate will learn novel chemistries, chemical biology, biophysical
techniques, with emphasis on antimicrobial synthesis, development and efficacy
determination to identify novel rRNA binding antibacterial therapeutics. The
success of the proposed work would be a significant addition to currently
available approaches in antibacterial therapy and train a promising candidate in
biomedical sciences.

## Key facts

- **NIH application ID:** 10835557
- **Project number:** 3R42AI114114-05S1
- **Recipient organization:** NUBAD, LLC
- **Principal Investigator:** DEV PRIYA ARYA
- **Activity code:** R42 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $133,089
- **Award type:** 3
- **Project period:** 2021-02-10 → 2026-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10835557

## Citation

> US National Institutes of Health, RePORTER application 10835557, Development of peptide nucleic acid antibiotics-supplement 1 (3R42AI114114-05S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10835557. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*